Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 224 participants.

Also called NCT01474200

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 224 participants (enrolled count) (from the registry)
Sponsor
Nuwellis, Inc. (from the registry)
Registry
  • NCT NCT01474200
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01474200. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-07 (actual). Results posted on 2015-10-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
Acronym
AVOID-HF
Condition
Heart Failure
Condition
Cardiac Failure
Condition
Acute Decompensated Heart Failure (ADHF)
Intervention (Device)
Isolated veno-venous ultrafiltration (AQ)
Intervention (Drug)
IV Loop Diuretics (LD)
Lead sponsor
Nuwellis, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01474200
Content hash
fe1d8bb0a30fccaa359f606437347822f6c1a886490b8314001dd6c629900c03